| S. |
GLP-1 Shot
Misses 1st Line Nod, Use W/Insulin; Launch Before 2009 Ends
Novo Nordisk A/S -- Regulatory Approval
combination treatment with metformin or a sulphonylurea in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin or sulphonylurea,
combination treatment with metformin and a sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycaemic control despite dual therapy
[Novo Press Release]
Novo Nordisk says Victoza cleared for EU market
thyroid tumours found in tests of rats and mice .1 months over a placebo for patients with advanced prostate cancer who had had no luck with hormonal therapy
Questions might arise over the benefit versus the cost
Some doctors will try it for patients with less-advanced cancers. |
| [Reuters]
."
Zhang and her fellow researchers compared spending on prescription drugs by about 35,000 people enrolled in the Medicare Advantage plan in Pennsylvania in the two years before implementation of Part D and the two years after. |
"
Zhang and her fellow researchers compared spending on prescription drugs by about 35,000 people enrolled in the Medicare Advantage plan in Pennsylvania in the two years before implementation of Part D and the two years after. Customs official, DEA official, or FDA official. |
| "
More information
The U. |
"The impact of Part D on medical spending really depended on prior drug coverage," Zhang said. |
|
"The impact of Part D on medical spending really depended on prior drug coverage," Zhang said. If the medication is a controlled substance, a reasonable amount means up to 50 combined total doses. |
7/7 Genzyme's Pain Is Upstart Israeli's Gain
FDA considers new Gaucher drug to offset Genzyme's plant shutdown
not yet been approved for use in the U. |
| That was the motivation, but no one has looked at definite results.
People who'd had no drug coverage increased their spending on drugs, on average, by 74 percent ($41 a month), those with a cap of $150 increased spending by 27 percent ($27 a month) and those with a $350 quarterly cap increased spending by 11 percent ($13), compared with the control group. |
* Although this is not a border issue, you should know that obtaining controlled substances from a foreign source via the internet or mail order is illegal unless you are an approved, registered importer with DEA. |
gov]
7/6 Zevalin: Complete Response Letter
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for Zevalin
Does Not Involve New Clinical Studies or New Data Analyses
FDA requested the Company to submit data files from the FIT study to support and verify a subset of the data that are currently under review
[Spectrum Pharmaceuticals Press Release]
7/6 Provenge Approval Possible Mid-1010 Launch;
Efficacy = Extra 4 Months Vs.
dicyclomine tramadol and domperidone |
, but would be used to blunt the effect of an expected shortage in Gaucher's disease drug made by Genzyme Corp
[BizJournal]
See Also: Protalix Asked to Widen Gaucher-Drug Supply
[Wall Street Journal; $$$]
See Also: Protalix's New Carrot Derived Drug Likely to Win FDA Approval
[CNBC]
7/7 Generic Maker Caraco Lays Off 1/2 Workforce; Quality Control Lapse
Caraco Pharmaceuticals lays off 350
jobs indefinitely after federal authorities shut down distribution at all the company's Michigan plants last month citing faulty manufacturing practices
[Detroit News]
See Also: Similar Report From NASDAQ; adds U. |
S.
tramadol withdrawal symptoms last |
Disclaimer: You may see advertisements on this page for cheap drugs from other countries or online stores. |
| citizen from prosecution in Mexico. It isn't worth the risks you are taking with your health and your freedom. |
3). |
| S. |
One surprise was that drug spending actually went up in the group that had the most coverage before joining Part D.
Serious Risks When You Buy Prescription Drugs in Mexico
* Drugs you purchase in Mexico may be counterfeit. |
|
At the time, 18 percent of people nationwide who were on Medicare had no drug coverage. |
com
Apotex said the only way to ensure the FDA grants approvals in 2010 is to clarify the rights involving all the patents
[Bloomberg]
7/7 Internet Drug News Miscellaneous Short Takes:
Biogen Reports No New PML Cases In Weekly Tysabri Update
NASDAQ
Internet-based therapy shows promise for insomnia
Newsday
Ipsen Afflicted by Too Many Drugs, Bucks Trend Infecting Others
Bloomberg
Hooligans Rob $7 mln Worth Of Levitra From Bayer Storehouse
UK Guardian
US stem cell research rules ease some restrictions
Reuters
McKesson Renews Pharmaceutical Distribution Agreement with CVS Caremark
McKesson Press Release
"Warning Signs" of severe flu
Reuters
7/6 EU: Once Daily Victoza Approved For Type 2; 1st Q. |